Time is precious when it comes to effective detection, diagnosis and treatment of breast cancer. We strive to save you time at every step along the Continuum of Care.
Designed for clinical confidence and effectiveness in treating heavy menstrual bleeding, perinatal diagnosis, and protecting sexual and reproductive health.
A comprehensive cervical cancer screening portfolio, from sample collection to diagnosis. This end-to-end solution meets the needs of most national screening programmes.
Expand your STI capabilities with Chlamydia, Gonorrhoea, Trichomonas vaginalis, Mycoplasma genitalium and Herpes testing on full automation.
Aptima assays offers clear, objective and qualitative results for the three most common causes of vaginitis, Bacterial vaginosis, Candida vaginitis and Trichomoniasis.
A single, patient friendly exam generates high-resolution images to accurately assess bone density, fracture risk and body composition.
Superior positioning, enhanced imaging and easy handling for extremities imaging to meet the demands of today’s surgeons.
A scalable portfolio combining a broad, high performing assay menu with high throughput automation, from a single patient rapid result to population level screening.
A comprehensive cervical cancer screening portfolio, from sample collection to diagnosis. This end-to-end solution meets the needs of most national screening programmes.
A scalable portfolio combining a broad, high performing assay menu with high throughput automation, from a single patient rapid result to population level screening.
A comprehensive cervical cancer screening portfolio, from sample collection to diagnosis. This end-to-end solution meets the needs of most national screening programmes.
A comprehensive cervical cancer screening portfolio, from sample collection to diagnosis. This end-to-end solution meets the needs of most national screening programmes.
A comprehensive cervical cancer screening portfolio, from sample collection to diagnosis. This end-to-end solution meets the needs of most national screening programmes.
A scalable portfolio combining a broad, high performing assay menu with high throughput automation, from a single patient rapid result to population level screening.
Developed for highly accurate results and simplified workflow, collection devices that support a comprehensive testing portfolio for women's health and infectious disease.
A worldwide standard for cervical sample collection and preservation, with more than 1 billion vials used globally for cervical cancer screening.
The product you are looking for is no longer part of Hologic's Molecular Diagnostics Portfolio. Browse our full portfolio here: